We know Brazilian pharma market is growing rapidly, but what will the next elections bring for Pharma industry

7 December 2009

There is no question that Brazil's pharmaceutical market is growing at an above average international rate and, like the other BRIC (Brazil, Russia, India and China) regions, is attracting a lot of attention from drugmakers. But what will next year's national elections ' due October 2010 - bring to the scenario?

Brazil's current President, Luiz Inacio Lula da Silva -p who has been in power for over seven years, has achieved success with social policies, but there have been significant problems in the area of health care. It is generally believed that health will be a major focus of the elections, with some likening this to the 'Obama agenda,' of the USA's President.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Generics